Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.

Saved in:
Bibliographic Details
Title: Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.
Authors: Labrenz J; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Edelmann D; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Kopp-Schneider A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Schlenk RF; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V and Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany.
Source: Pharmaceutical statistics [Pharm Stat] 2023 Mar; Vol. 22 (2), pp. 236-247. Date of Electronic Publication: 2022 Oct 25.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36285348
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Labrenz+J%22">Labrenz J</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Edelmann+D%22">Edelmann D</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heitmann+JS%22">Heitmann JS</searchLink>; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Salih+HR%22">Salih HR</searchLink>; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kopp-Schneider+A%22">Kopp-Schneider A</searchLink>; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlenk+RF%22">Schlenk RF</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V and Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101201192%22">Pharmaceutical statistics</searchLink> [Pharm Stat] 2023 Mar; Vol. 22 (2), pp. 236-247. <i>Date of Electronic Publication: </i>2022 Oct 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101201192 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1539-1612 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215391604%22">15391604 </searchLink><i>NLM ISO Abbreviation: </i>Pharm Stat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36285348
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pst.2268
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 236
    Titles:
      – TitleFull: Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labrenz J
      – PersonEntity:
          Name:
            NameFull: Edelmann D
      – PersonEntity:
          Name:
            NameFull: Heitmann JS
      – PersonEntity:
          Name:
            NameFull: Salih HR
      – PersonEntity:
          Name:
            NameFull: Kopp-Schneider A
      – PersonEntity:
          Name:
            NameFull: Schlenk RF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1539-1612
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Pharmaceutical statistics
              Type: main
ResultId 1